Home / Inspections / 1085858

FDA Inspection 1085858 — USC Reproductive Endocrinology and Infertility

USC Reproductive Endocrinology and Infertility — FEI 3004715781

The FDA completed an inspection of USC Reproductive Endocrinology and Infertility on March 21, 2019 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 21, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)

Facility

Other inspections at this facility

  • 986030 (NAI Wed Jun 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 732291 (NAI Fri Jun 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources